Peter George Deutsch
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Peter George Deutsch has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
Aakash D Amlani
Birmingham Heartlands Hospital, University Hospitals Birmingham Foundation Trust, Birmingham
1 shared publicationAman Khanna
Birmingham Heartlands Hospital, University Hospitals Birmingham Foundation Trust, Birmingham
1 shared publicationAnindya Lahiri
Department of Plastic Reconstructive and Hand Surgery, Sandwell and West Birmingham Hospitals NHS Trust, West Bromwich, UK
1 shared publication- Ann-Louise McDermott
Birmingham Children's Hospital, Steelhouse Ln, Birmingham, B4 6NH, UK
1 shared publication Catherine Evans
Pontardawe Primary Care Centre, Swansea Bay Health Board, Swansea
1 shared publicationJanet O'Connell
Department of Otolaryngology, Sandwell and West Birmingham Hospitals NHS Trust, Birmingham, UK
1 shared publication
Latest Publications
- 1 November 2023
- Published by Springer Nature
- p. 199-213
Paediatric Rhinosinusitis
- 25 February 2021
- Published by Royal College of General Practitioners in British Journal of General Practice
- Vol. 71 (704) , 135-138
Anosmia: an evidence-based approach to diagnosis and management in primary care
As one of our five key senses, disturbances in smell have a profound effect on patients’ quality of life, with strong associations with mental health disease.5 Smell is essential for protecting against dangers of day-to-day life, including smelling gas leaks and identifying spoilt food. Despite this, the condition is poorly understood and often dismissed as a symptom in both primary and secondary care. This may be as it is often accompanied by other, more well-understood conditions such as nasal blockage, or if it presents in isolation is thought to be a non-sinister symptom. Box 1 includes a list of definitions for anosmia and related conditions.
- 25 February 2021
- Published by Royal College of General Practitioners in British Journal of General Practice
- Vol. 71 (704) , 135-138
Anosmia: an evidence-based approach to diagnosis and management in primary care
As one of our five key senses, disturbances in smell have a profound effect on patients’ quality of life, with strong associations with mental health disease.5 Smell is essential for protecting against dangers of day-to-day life, including smelling gas leaks and identifying spoilt food. Despite this, the condition is poorly understood and often dismissed as a symptom in both primary and secondary care. This may be as it is often accompanied by other, more well-understood conditions such as nasal blockage, or if it presents in isolation is thought to be a non-sinister symptom. Box 1 includes a list of definitions for anosmia and related conditions.
- Top Cited PapersOpen Access
Invasive and Non-Invasive Fungal Rhinosinusitis—A Review and Update of the Evidence
Fungal infections are a subset of infectious processes that an otolaryngologist is required to be familiar with. They can be encountered in otology, rhinology and head and neck surgery. The presence of fungal rhinosinusitis is well recognised by otolaryngologists, but the classifications and appropriate management are not so well understood. The prevalence of fungal sinus disease is thought to be have been increasing in recent decades There is speculation that this may be due to increased awareness, antibiotic overuse and increased use of immunosuppressant medications. Added to this, there has been a large amount published on the role of fungi as a causative organism in chronic rhinosinusitis. Given the importance of fungal rhinosinusitis in clinical practice, we aim to review the classification and current management strategies based on up-to-date literature.
Top Cited PapersOpen AccessInvasive and Non-Invasive Fungal Rhinosinusitis—A Review and Update of the Evidence
Fungal infections are a subset of infectious processes that an otolaryngologist is required to be familiar with. They can be encountered in otology, rhinology and head and neck surgery. The presence of fungal rhinosinusitis is well recognised by otolaryngologists, but the classifications and appropriate management are not so well understood. The prevalence of fungal sinus disease is thought to be have been increasing in recent decades There is speculation that this may be due to increased awareness, antibiotic overuse and increased use of immunosuppressant medications. Added to this, there has been a large amount published on the role of fungi as a causative organism in chronic rhinosinusitis. Given the importance of fungal rhinosinusitis in clinical practice, we aim to review the classification and current management strategies based on up-to-date literature.
- 27 December 2018
- Published by Royal College of General Practitioners in British Journal of General Practice
- Vol. 69 (678) , 44-45
The management of chronic rhinosinusitis in primary care: an evidence-based guide
Presentations to general practice with the myriad of symptoms associated with chronic rhinosinusitis (CRS) are extremely common. The mainstay of management of this condition is carried out in primary care.1 This article covers the diagnosis and management of adult CRS in the light of evidence from the European position paper from 2012 on this condition.2 CRS is reported to affect 5–15% of the general population but only 2–4% of this is diagnosed by a doctor.3 Awareness of the relevant definitions will aid diagnosis and management of this common, but underdiagnosed, condition. Adult rhinosinusitis is defined as: ‘Inflammation of the nose and paranasal sinuses characterised by two or more of the following symptoms.’ 2 At least one of these must be: Other ‘non-essential’ symptoms that contribute to diagnosis include: Continuation of symptoms for >12 weeks differentiates chronic from acute rhinosinusitis.1 This definition can be refined with the aid of flexible nasendoscopy. This can help subdivide patients with CRS into two groups: those with and without nasal polyps.2 Patients with CRS may present to general practice with a wide array of symptoms.1 Along with those identified above there are a range of symptoms including:3,4 The use of symptom severity scales, such as the visual analogue scale …
- 27 December 2018
- Published by Royal College of General Practitioners in British Journal of General Practice
- Vol. 69 (678) , 44-45
The management of chronic rhinosinusitis in primary care: an evidence-based guide
Presentations to general practice with the myriad of symptoms associated with chronic rhinosinusitis (CRS) are extremely common. The mainstay of management of this condition is carried out in primary care.1 This article covers the diagnosis and management of adult CRS in the light of evidence from the European position paper from 2012 on this condition.2 CRS is reported to affect 5–15% of the general population but only 2–4% of this is diagnosed by a doctor.3 Awareness of the relevant definitions will aid diagnosis and management of this common, but underdiagnosed, condition. Adult rhinosinusitis is defined as: ‘Inflammation of the nose and paranasal sinuses characterised by two or more of the following symptoms.’ 2 At least one of these must be: Other ‘non-essential’ symptoms that contribute to diagnosis include: Continuation of symptoms for >12 weeks differentiates chronic from acute rhinosinusitis.1 This definition can be refined with the aid of flexible nasendoscopy. This can help subdivide patients with CRS into two groups: those with and without nasal polyps.2 Patients with CRS may present to general practice with a wide array of symptoms.1 Along with those identified above there are a range of symptoms including:3,4 The use of symptom severity scales, such as the visual analogue scale …
- 6 January 2017
- Published by BMJ in BMJ Case Reports
- Vol. 2017
Epirubicin extravasation: consequences of delayed management
Epirubicin is an anthracycline chemotherapy agent used for treatment of several cancers including oesophageal, breast and gastric. Extravasation is a well-recognised and serious complication of any intravenous therapies but especially chemotherapeutic agents. Signs of the injury can be subtle and without prompt recognition and treatment there can be extensive tissue damage and depending on location of injury this can result in significant functional loss. In this article, a case of delayed management of epirubicin extravasation from a cannula situated at the dorsum of the hand is discussed. Successful surgical reconstruction of the resulting substantial tissue damage using a radial forearm flap 21 days following injury is described.
- 6 January 2017
- Published by BMJ in BMJ Case Reports
- Vol. 2017
Epirubicin extravasation: consequences of delayed management
Epirubicin is an anthracycline chemotherapy agent used for treatment of several cancers including oesophageal, breast and gastric. Extravasation is a well-recognised and serious complication of any intravenous therapies but especially chemotherapeutic agents. Signs of the injury can be subtle and without prompt recognition and treatment there can be extensive tissue damage and depending on location of injury this can result in significant functional loss. In this article, a case of delayed management of epirubicin extravasation from a cannula situated at the dorsum of the hand is discussed. Successful surgical reconstruction of the resulting substantial tissue damage using a radial forearm flap 21 days following injury is described.
- 22 April 2016
- Published by BMJ in BMJ Case Reports
- Vol. 2016
Laryngeal lipoma: a rare cause of acute intermittent airway obstruction
We present a case of a 62-year-old man with a lipoma in the exceedingly rare location of the larynx, causing intermittent airway obstruction and dysphagia. The lipoma was excised endoscopically with complete resolution of symptoms. Lipomas are relatively common, accounting for 4–5% of all benign tumours in the body. They traditionally occur in areas of large depositions of subcutaneous fat, most frequently the trunk and limbs. They are recognised to occur in the head and neck but these only represent 13–15% of all lipomas. Lipomas are typically asymptomatic unless their impingement of nearby structures causes symptoms.
- 22 April 2016
- Published by BMJ in BMJ Case Reports
- Vol. 2016
Laryngeal lipoma: a rare cause of acute intermittent airway obstruction
We present a case of a 62-year-old man with a lipoma in the exceedingly rare location of the larynx, causing intermittent airway obstruction and dysphagia. The lipoma was excised endoscopically with complete resolution of symptoms. Lipomas are relatively common, accounting for 4–5% of all benign tumours in the body. They traditionally occur in areas of large depositions of subcutaneous fat, most frequently the trunk and limbs. They are recognised to occur in the head and neck but these only represent 13–15% of all lipomas. Lipomas are typically asymptomatic unless their impingement of nearby structures causes symptoms.
- 8 January 2016
- Published by Wiley in BJU International
- Vol. 118 (3) , 444-450
Conservative management of staghorn calculi: a single‐centre experience
Objective: To evaluate the outcomes of conservatively managed staghorn calculi, specifically looking at morbidity and mortality, incidence of infections and progressive changes in renal function. Patients and Methods: A total of 22 patients with unilateral or bilateral staghorn calculi, who were treated conservatively, were included in the study. Patients were reviewed yearly with symptom assessment, urine culture and measurement of estimated glomerular filtration rate. Results: The presentations to the urology department of staghorn calculi were incidental (41%), haematuria (36%), abdominal discomfort (5%) and recurrent urinary tract infections ( UTI s; 18%). The reasons for conservative management in the cohort were comorbidities (59%), patient choice (36%) or poor access/anatomy (5%). In the whole cohort the rate of recurrent UTI s was 50%, the progressive renal failure rate was 14%, the disease‐specific mortality rate was 9%, the dialysis dependence rate was 9% and the rate of hospital attendances attributable to stone‐related morbidity was 27%. Comparison of outcome measures between the unilateral and bilateral staghorn stones showed statistically significant differences in disease‐specific mortality (0 vs 40%) and morbidity (12 vs 80%) in favour of the unilateral group. Although there was a lower incidence of UTI s (41 vs 80%), renal deterioration (6 vs 40%) and dialysis requirement (6 vs 20%) in the unilateral group, these findings were not statistically significant. Conclusions: From the results, we conclude that conservative management of staghorn calculi is not as unsafe as previously thought. Careful patient selection to include unilateral asymptomatic stones with minimal infection, and thorough counselling with regard to the risks, could make conservative management a suitable option for specific patient groups.
- 8 January 2016
- Published by Wiley in BJU International
- Vol. 118 (3) , 444-450
Conservative management of staghorn calculi: a single‐centre experience
Objective: To evaluate the outcomes of conservatively managed staghorn calculi, specifically looking at morbidity and mortality, incidence of infections and progressive changes in renal function. Patients and Methods: A total of 22 patients with unilateral or bilateral staghorn calculi, who were treated conservatively, were included in the study. Patients were reviewed yearly with symptom assessment, urine culture and measurement of estimated glomerular filtration rate. Results: The presentations to the urology department of staghorn calculi were incidental (41%), haematuria (36%), abdominal discomfort (5%) and recurrent urinary tract infections ( UTI s; 18%). The reasons for conservative management in the cohort were comorbidities (59%), patient choice (36%) or poor access/anatomy (5%). In the whole cohort the rate of recurrent UTI s was 50%, the progressive renal failure rate was 14%, the disease‐specific mortality rate was 9%, the dialysis dependence rate was 9% and the rate of hospital attendances attributable to stone‐related morbidity was 27%. Comparison of outcome measures between the unilateral and bilateral staghorn stones showed statistically significant differences in disease‐specific mortality (0 vs 40%) and morbidity (12 vs 80%) in favour of the unilateral group. Although there was a lower incidence of UTI s (41 vs 80%), renal deterioration (6 vs 40%) and dialysis requirement (6 vs 20%) in the unilateral group, these findings were not statistically significant. Conclusions: From the results, we conclude that conservative management of staghorn calculi is not as unsafe as previously thought. Careful patient selection to include unilateral asymptomatic stones with minimal infection, and thorough counselling with regard to the risks, could make conservative management a suitable option for specific patient groups.